Background Background Smoking may have a
Smoking may have a beneficial effect on either schizophrenic beneficial effect on either schizophrenic symptoms or antipsychotic side-effects, symptoms or antipsychotic side-effects, but studies are hampered by the lack of but studies are hampered by the lack of control of confounding factors. control of confounding factors.
Aims Aims To explore the self-medication
To explore the self-medication hypothesis in a large sample of stable outhypothesis in a large sample of stable outpatients with schizophrenia. patients with schizophrenia.
Method
Method Symptoms, assessed with the Symptoms, assessed with the Positive and Negative Syndrome Scale Positive and Negative Syndrome Scale (PANSS), and number of hospitalisations (PANSS), and number of hospitalisations were compared in 250 out-patients with were compared in 250 out-patients with DSM^IV schizophrenia classified into DSM^IV schizophrenia classified into three categories: highly dependent three categories: highly dependent smokers, mildly dependent smokers and smokers, mildly dependent smokers and non-smokers.Log-linear analysis was used non-smokers.Log-linear analysis was used to control for potential confounding and to control for potential confounding and interacting variables. interacting variables.
Results
Results High PANSS total scores and High PANSS total scores and positive symptoms were less frequent in positive symptoms were less frequent in mildly dependent smokers than in nonmildly dependent smokers than in nonsmokers or highly dependent smokers. smokers or highly dependent smokers. The highly dependent smokers had the The highly dependent smokers had the worst outcome. worst outcome.
Conclusions Conclusions The data do not generally
The data do not generally supportthe self-medication hypothesis supportthe self-medication hypothesis but rather suggest a complex interaction but rather suggest a complex interaction between nicotine dependence and between nicotine dependence and schizophrenic symptoms. schizophrenic symptoms.
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Schizophrenia is associated worldwide with Schizophrenia is associated worldwide with a higher rate of smoking than that observed a higher rate of smoking than that observed among the general population or those with among the general population or those with other severe mental illnesses (McCreadie, other severe mental illnesses (McCreadie, 2002; Llerena 2002; Llerena et al et al, 2003) . This association , 2003) . This association persists after correcting for such confoundpersists after correcting for such confounding factors as antipsychotic medication, ining factors as antipsychotic medication, institutionalisation or alcohol and drug use stitutionalisation or alcohol and drug use (de Leon (de Leon et al et al, 1995 Leon et al et al, , 2002 Leon et al et al, , 1995 Leon et al et al, , 2002a Llerena ; Llerena et al et al, , 2003) . Smoking might be a marker of a 2003). Smoking might be a marker of a more severe illness or might have a benemore severe illness or might have a beneficial effect in schizophrenia by improving ficial effect in schizophrenia by improving its symptoms and/or decreasing extrapyraits symptoms and/or decreasing extrapyramidal side-effects of antipsychotics -'the midal side-effects of antipsychotics -'the self-medication hypothesis' (Lohr & Flynn, self-medication hypothesis' (Lohr & Flynn, 1992; Ziedonis 1992; Ziedonis et al et al, 1994; Dalack , 1994; Dalack et al et al, , 1998) . This study explores both the self-1998). This study explores both the selfmedication hypothesis and the hypothesis medication hypothesis and the hypothesis that severe forms of schizophrenia are that severe forms of schizophrenia are associated with high levels of nicotine associated with high levels of nicotine dependence. dependence.
METHOD METHOD Patients Patients
The study was located at two community The study was located at two community mental health centres and their rehabilitamental health centres and their rehabilitation unit, covering the catchment area of tion unit, covering the catchment area of the city of Granada (southern Spain). All the city of Granada (southern Spain). All participants received free psychiatric treatparticipants received free psychiatric treatment from the national health system. The ment from the national health system. The sample included the first 250 consecutive sample included the first 250 consecutive patients with a diagnosis of DSM-IV patients with a diagnosis of DSM-IV (American Psychiatric Association, 1994) (American Psychiatric Association, 1994) schizophrenia who provided written inschizophrenia who provided written informed consent after a complete description formed consent after a complete description of the study (18 of 278 patients refused to of the study (18 of 278 patients refused to participate; 10 additional excluded patients participate; 10 additional excluded patients had a chart diagnosis of schizophrenia but had a chart diagnosis of schizophrenia but did not meet the DSM-IV diagnosis). The did not meet the DSM-IV diagnosis). The diagnosis was made with the clinician verdiagnosis was made with the clinician version of a structured diagnostic interview sion of a structured diagnostic interview (First (First et al et al, 1994 There is no There is no reason to believe that the reason to believe that the selfself-reported smoking of these patients reported smoking of these patients was unreliable, because until recently was unreliable, because until recently smoking has been socially acceptable in smoking has been socially acceptable in Spain. Moreover, a reliable self-report of Spain. Moreover, a reliable self-report of smoking or non-smoking status was prosmoking or non-smoking status was provided by a subsample of 99 participants vided by a subsample of 99 participants (of the 250 studied) whose cotinine in (of the 250 studied) whose cotinine in saliva was measured by radioimmunoassay. saliva was measured by radioimmunoassay.
Variables Variables
All ratings were conducted by a research All ratings were conducted by a research psychiatrist (M.C.A.). Table 1 describes psychiatrist (M.C.A.). Table 1 describes the variables used in statistical analyses. the variables used in statistical analyses. In order to avoid bias in the assessment, In order to avoid bias in the assessment, the clinical evaluation was conducted the clinical evaluation was conducted first, and information concerning medifirst, and information concerning medication and substance use, including tobacco cation and substance use, including tobacco and nicotine dependence, was gathered and nicotine dependence, was gathered afterwards. afterwards.
All variables were dichotomised except All variables were dichotomised except nicotine dependence, which was given three nicotine dependence, which was given three categories. On the basis of the Fagerstrom categories. On the basis of the Fagerströ m Test for Nicotine Dependence (FTND), Test for Nicotine Dependence (FTND), smokers were classified as very highly smokers were classified as very highly dependent (FTND dependent (FTND 4 47; smoking a median 7; smoking a median of 40 cigarettes/day) or not very highly of 40 cigarettes/day) or not very highly dependent (FTND dependent (FTND 4 47; median of 20 7; median of 20 cigarettes/day) (Fagerstrom cigarettes/day) (Fagerströ m et al et al, 1990) . , 1990). The three categories will be called highly The three categories will be called highly dependent smokers, mildly dependent dependent smokers, mildly dependent smokers and non-smokers. Schizophrenic smokers and non-smokers. Schizophrenic symptomatology was assessed with the symptomatology was assessed with the Spanish version of the Positive and Spanish version of the Positive and Negative Syndrome Scale (PANSS; Peralta Negative Syndrome Scale (PANSS; Peralta & Cuesta, 1994) . The PANSS total scores & Cuesta, 1994) . The PANSS total scores were divided into high ( were divided into high (5 545) and low 45) and low scores. The negative, positive, disorganised, scores. The negative, positive, disorganised, excited, anxious and depressed factors of excited, anxious and depressed factors of the PANSS were calculated by adding the the PANSS were calculated by adding the scores of the items with a loading higher scores of the items with a loading higher than 0.50 in the factor (Peralta & Cuesta, than 0.50 in the factor (Peralta & Cuesta, 1994) , and dividing by the number of those 1994), and dividing by the number of those items. Subjects with a score items. Subjects with a score 5 52 for a factor 2 for a factor 21 5 21 5 Table 1 footnote). In summary, factor, see Table 1 footnote). In summary, the presence of symptoms with regard to a the presence of symptoms with regard to a factor (e.g. positive symptoms) in these factor (e.g. positive symptoms) in these clinically stable out-patients suggests that clinically stable out-patients suggests that despite treatment they continue to have sufdespite treatment they continue to have sufficient positive symptoms to be identified ficient positive symptoms to be identified through a standardised assessment. through a standardised assessment. The Simpson & Angus (1970) NeuroThe Simpson & Angus (1970) Neurological Rating Scale was used to measure logical Rating Scale was used to measure parkinsonian side-effects. Akathisia was parkinsonian side-effects. Akathisia was assessed with the Barnes Akathisia Scale assessed with the Barnes Akathisia Scale (Barnes, 1989) . Some patients might have (Barnes, 1989) . Some patients might have extrapyramidal side-effects previously corextrapyramidal side-effects previously corrected by antiparkinsonian drugs, therefore rected by antiparkinsonian drugs, therefore vulnerability to extrapyramidal side-effects vulnerability to extrapyramidal side-effects was defined as the occurrence of at least was defined as the occurrence of at least one of the three following conditions: one of the three following conditions: current treatment with antiparkinsonian current treatment with antiparkinsonian medication; a score of medication; a score of 4 40 on the neuro-0 on the neurological rating scale; or a score of logical rating scale; or a score of 4 40 on 0 on the Barnes Akathisia Scale (presence of the Barnes Akathisia Scale (presence of akathisia). akathisia).
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
A high antipsychotic dose was defined A high antipsychotic dose was defined as a chlorpromazine equivalent of as a chlorpromazine equivalent of 5 510 mg/kg per day. Current alcohol and 10 mg/kg per day. Current alcohol and caffeine intake was assessed by interview caffeine intake was assessed by interview and verified by chart review and collateral and verified by chart review and collateral information from the family (with whom information from the family (with whom most patients live in Spain). Owing to the most patients live in Spain). Owing to the small number of patients using illegal drugs small number of patients using illegal drugs (7%, 17/250), a drug-use variable was not (7%, 17/250), a drug-use variable was not included in the analysis. included in the analysis.
Finally, a high number of hospitalisaFinally, a high number of hospitalisations after correcting for duration of illness tions after correcting for duration of illness was used for the longitudinal definition of was used for the longitudinal definition of the severity of psychiatric symptoms. the severity of psychiatric symptoms.
Statistics Statistics
The Statistical Package for the Social The Statistical Package for the Social Sciences (version 11.0) was used for calcuSciences (version 11.0) was used for calculations (SPSS, 1997) . Initially, the three lations (SPSS, 1997) . Initially, the three groups were compared by univariate groups were compared by univariate parametric or non-parametric tests, as parametric or non-parametric tests, as appropriate. Then, log-linear analyses of appropriate. Then, log-linear analyses of the data were performed ; the data were performed SPSS, 1997) ; the log-linear analyses had SPSS, 1997); the log-linear analyses had two main purposes: they tested the two main purposes: they tested the hypothesis of a significant association of hypothesis of a significant association of nicotine dependence with schizophrenic nicotine dependence with schizophrenic symptomatology, as measured by either symptomatology, as measured by either the PANSS total score (or each one of its the PANSS total score (or each one of its factors) or the number of hospitalisations; factors) or the number of hospitalisations; and they described the strength and direcand they described the strength and direction of such association across different tion of such association across different combinations of levels of potential interactcombinations of levels of potential interacting variables such as gender, antipsychotic ing variables such as gender, antipsychotic dose/type and caffeine and alcohol intake. dose/type and caffeine and alcohol intake. Strength and direction of associations were Strength and direction of associations were measured with odds ratios and their 95% measured with odds ratios and their 95% confidence intervals from cross-tabulations. confidence intervals from cross-tabulations.
In a first analysis, the association In a first analysis, the association between nicotine dependence and PANSS between nicotine dependence and PANSS total score was tested while controlling for total score was tested while controlling for gender, antipsychotic dose/type and cafgender, antipsychotic dose/type and caffeine and alcohol intake. This was perfeine and alcohol intake. This was performed by including the seven variables in formed by including the seven variables in a saturated log-linear model. Table 2 shows a saturated log-linear model. Table 2 shows the significant interactions that were obthe significant interactions that were obtained. The significances of interaction tained. The significances of interaction were tested using partial were tested using partial w w 2 2 (SPSS, 1997).
(SPSS, 1997). A significant interaction between two A significant interaction between two variables was interpreted as evidence that variables was interpreted as evidence that the two variables were associated, even the two variables were associated, even when controlling for the other variables in when controlling for the other variables in 21 6 21 6 the model. Analyses similar to that of the the model. Analyses similar to that of the PANSS total score were repeated for num-PANSS total score were repeated for number of admissions (Table 3 ) and for ber of admissions (Table 3 ) and for negative, positive, disorganised, excited, negative, positive, disorganised, excited, anxious and depressed PANSS factors anxious and depressed PANSS factors (results not presented).
(results not presented).
A second purpose of the statistical A second purpose of the statistical analyses was to describe the association analyses was to describe the association between nicotine dependence and schizobetween nicotine dependence and schizophrenic symptomatology across different phrenic symptomatology across different combinations of levels of other variables. combinations of levels of other variables. One difficulty was that the relatively high One difficulty was that the relatively high number of variables considered in this number of variables considered in this study produced many possible combinastudy produced many possible combinations. Some variables represented a small tions. Some variables represented a small sample size; for instance, the five dichotosample size; for instance, the five dichotomous variables (gender, antipsychotic dose mous variables (gender, antipsychotic dose and type and caffeine and alcohol intake) and type and caffeine and alcohol intake) produced 2 produced 2 5 5 ¼32 possible combinations of 32 possible combinations of levels. It is not practical or statistically advilevels. It is not practical or statistically advisable to perform so many cross-tabulations. sable to perform so many cross-tabulations. Because odds ratios are rather inaccurate Because odds ratios are rather inaccurate with small sample sizes, a systematic methwith small sample sizes, a systematic methodology that discarded irrelevant variables odology that discarded irrelevant variables was used (SPSS, 1997) . This methodology was used (SPSS, 1997) . This methodology was based on the collapsibility conditions was based on the collapsibility conditions ; the rationale behind the ; the rationale behind the collapsibility conditions is that variables collapsibility conditions is that variables that do not affect an association can be exthat do not affect an association can be excluded from the analysis of that association cluded from the analysis of that association (group B of variables in Tables 2 and 3),  (group B of variables in Tables 2 and 3) , even if those variables have an effect on even if those variables have an effect on one of the variables involved in the associaone of the variables involved in the association. The above analyses were repeated by tion. The above analyses were repeated by including vulnerability to extrapyramidal including vulnerability to extrapyramidal side-effects as an additional variable. side-effects as an additional variable.
RESULTS RESULTS
Among the 250 patients there were 173 Among the 250 patients there were 173 (69%) current smokers and 77 (31%) (69%) current smokers and 77 (31%) non-smokers (including 7 (4%) former non-smokers (including 7 (4%) former smokers and 70 (27%) that had never smokers and 70 (27%) that had never smoked daily). As expected, the rate of smoked daily). As expected, the rate of smoking was higher in our sample than smoking was higher in our sample than among the Spanish general population among the Spanish general population (Pinilla & Gonzalez, 2001 ) for both males (Pinilla & Gonzá lez, 2001) for both males (75% (75% v v. 45%) and females (49% . 45%) and females (49% v v. 27%). . 27%). Table 1 shows the variable distribution  Table 1 shows the variable distribution across the three groups of nicotine depenacross the three groups of nicotine dependence. There were no significant differences dence. There were no significant differences in current age, age at diagnosis or educain current age, age at diagnosis or educational level. The mean (s.d.) PANSS total tional level. The mean (s.d.) PANSS total score was 45.7 (10.7) for non-smokers, score was 45.7 (10.7) for non-smokers, 41.7 (9.2) for mildly dependent smokers 41.7 (9.2) for mildly dependent smokers and 47.9 (14.1) for highly dependent smoand 47.9 (14.1) for highly dependent smokers (Kruskal-Wallis kers (Kruskal-Wallis w w 27.9, d.f.¼2, 2, P P5 50.0001). The levels 0.0001). The levels (median) of cotinine (ng/ml) in saliva in (median) of cotinine (ng/ml) in saliva in the 99 participants for whom it was deterthe 99 participants for whom it was determined were: 551 in highly dependent smomined were: 551 in highly dependent smokers ( kers (n n¼31), 423 in mildly dependent 31), 423 in mildly dependent smokers ( smokers (n n¼29) and 0.6 in non-smokers 29) and 0.6 in non-smokers ( (n n¼29). 29).
Symptom score and nicotine Symptom score and nicotine dependence dependence Table 2 shows results from the log-linear Table 2 shows results from the log-linear model that included nicotine dependence model that included nicotine dependence and the variables listed in the first and the variables listed in the first column. The interaction between nicotine column. The interaction between nicotine dependence and PANSS total score was dependence and PANSS total score was significantly different from zero, indicating significantly different from zero, indicating that these two variables were significantly that these two variables were significantly associated when controlling for the other associated when controlling for the other variables (gender, antipsychotic dose and variables (gender, antipsychotic dose and type, caffeine and alcohol intake). Nicotine type, caffeine and alcohol intake). Nicotine dependence was significantly associated dependence was significantly associated with other variables (gender, antipsychotic with other variables (gender, antipsychotic dose and type, and caffeine intake). Two dose and type, and caffeine intake). Two groups of variables can be identified from groups of variables can be identified from Table 2 : group A, comprising PANSS total Table 2 : group A, comprising PANSS total score and antipsychotic dose and type; score and antipsychotic dose and type; and group B, comprising gender and cafand group B, comprising gender and caffeine and alcohol intake. Nicotine depenfeine and alcohol intake. Nicotine dependence was associated significantly with all dence was associated significantly with all the variables of group A and some variables the variables of group A and some variables of group B. However, the variables of of group B. However, the variables of group A were not associated with the varigroup A were not associated with the variables of group B. In fact, no significant ables of group B. In fact, no significant interactions simultaneously involving interactions simultaneously involving variables of A and variables of B were variables of A and variables of B were found. By virtue of the collapsibility condifound. By virtue of the collapsibility conditions, the strength and direction of the assotions, the strength and direction of the association between PANSS total score and ciation between PANSS total score and nicotine dependence do not vary across nicotine dependence do not vary across the levels of caffeine or alcohol intake, the levels of caffeine or alcohol intake, gender or across combinations of those gender or across combinations of those levels. Thus, this association can be studied levels. Thus, this association can be studied by controlling only for antipsychotic dose by controlling only for antipsychotic dose and type. and type.
The association between PANSS total The association between PANSS total score and nicotine dependence was therescore and nicotine dependence was therefore studied with cross-tabulations for each fore studied with cross-tabulations for each of the four combinations of antipsychotic of the four combinations of antipsychotic doses and types. The association was most doses and types. The association was most significant among those on a low dose of significant among those on a low dose of typical antipsychotics (Fig. 1) . In these subtypical antipsychotics (Fig. 1) . In these subjects, mildly dependent smokers included jects, mildly dependent smokers included the lowest number of subjects with clinithe lowest number of subjects with clinically meaningful symptoms in the total cally meaningful symptoms in the total PANSS. Among those on a low PANSS. Among those on a low dose of a dose of a typical antipsychotic, nontypical antipsychotic, non-smokers have smokers have an odds ratio of 2.7 of having a high an odds ratio of 2.7 of having a high PANSS total score when compared with PANSS total score when compared with mildly dependent smokers (Fig. 1) . In other mildly dependent smokers (Fig. 1) . In other words, the percentage of patients with high words, the percentage of patients with high total scores was significantly lower in total scores was significantly lower in mildly dependent smokers than among mildly dependent smokers than among non-smokers or highly dependent smokers. non-smokers or highly dependent smokers.
When vulnerability to extrapyramidal When vulnerability to extrapyramidal side-effects was also included in the logside-effects was also included in the loglinear model, the significant interactions linear model, the significant interactions were the same as in Table 2 ; additionally, were the same as in Table 2 ; additionally, 217 217 a significant interaction between antia significant interaction between antipsychotic type and vulnerability to extrapsychotic type and vulnerability to extrapyramidal side-effects, and a significant pyramidal side-effects, and a significant interaction between PANSS total score interaction between PANSS total score and vulnerability to extrapyramidal sideand vulnerability to extrapyramidal sideeffects were found (see footnote to effects were found (see footnote to Table 2 ). The association between Table 2 ). The association between PANSS total score and nicotine dependence PANSS total score and nicotine dependence was close to significant for those on a was close to significant for those on a low dose of typical antipsychotic low dose of typical antipsychotic medication who showed vulnerability to medication who showed vulnerability to extrapyramidal side-effects (Fig. 1) ; extrapyramidal side-effects (Fig. 1) ; among these, mildly dependent smokers inamong these, mildly dependent smokers included the lowest number with clinically cluded the lowest number with clinically meaningful symptoms in the PANSS total meaningful symptoms in the PANSS total score. score. The analysis of the positive factor The analysis of the positive factor was very similar to the analysis of the was very similar to the analysis of the PANSS PANSS total score and supported the total score and supported the selfself-medication hypothesis for those on a medication hypothesis for those on a low dose of typical antipsychotics who are low dose of typical antipsychotics who are mildly dependent smokers. mildly dependent smokers.
Negative, depressive or anxious sympNegative, depressive or anxious symptoms were not significantly associated with toms were not significantly associated with nicotine dependence (Table 1) . Thus, the nicotine dependence (Table 1) . Thus, the analyses of these symptoms did not support analyses of these symptoms did not support the self-medication hypothesis. Neither the the self-medication hypothesis. Neither the disorganised nor the excited PANSS factor, disorganised nor the excited PANSS factor, after analysis, supported the self-medication after analysis, supported the self-medication hypothesis. Moreover, disorganised resihypothesis. Moreover, disorganised residual symptoms were associated with heavy dual symptoms were associated with heavy smoking (see next section). smoking (see next section).
Number of admissions and nicotine Number of admissions and nicotine dependence dependence Table 1 shows that highly dependent Table 1 shows that highly dependent smokers had the highest proportion of smokers had the highest proportion of hospital admissions compared with mildly hospital admissions compared with mildly dependent smokers (odds ratio dependent smokers (odds ratio¼3.0) and 3.0) and non-smokers (odds ratio non-smokers (odds ratio¼3.9) (see also 3.9) (see also Fig. 2) . Fig. 2 ).
When the disorganised symptom variWhen the disorganised symptom variable was considered in the analysis, the able was considered in the analysis, the association between nicotine dependence association between nicotine dependence and number of admissions was significant and number of admissions was significant only for those without disorganised only for those without disorganised symptoms (Fig. 2) . symptoms (Fig. 2) .
DISCUSSION DISCUSSION
The self-medication hypothesis of The self-medication hypothesis of smoking in schizophrenia smoking in schizophrenia
There is a discrepancy in the literature, with There is a discrepancy in the literature, with numerous animal studies suggesting that numerous animal studies suggesting that nicotine should help negative symptoms nicotine should help negative symptoms but scarce clinical data suggesting that this but scarce clinical data suggesting that this may be true in those with schizophrenia may be true in those with schizophrenia (Hughes, 2000) . Two main sub-hypotheses (Hughes, 2000) . Two main sub-hypotheses are usually included in the self-medication are usually included in the self-medication hypothesis: smoking reduces the side-effects hypothesis: smoking reduces the side-effects of antipsychotics; and nicotine may imof antipsychotics; and nicotine may improve schizophrenic symptoms, particularly prove schizophrenic symptoms, particularly the negative, cognitive and/or depressive the negative, cognitive and/or depressive symptoms (Taiminen symptoms (Taiminen et al et al, 1998) . , 1998). Two mechanisms have been implicated Two mechanisms have been implicated in the reduction of antipsychotic sidein the reduction of antipsychotic sideeffects: a release of dopamine resulting effects: a release of dopamine resulting from the administration of nicotine, a from the administration of nicotine, a notion supported by both acute administranotion supported by both acute administration of nicotine in animal models (Drew tion of nicotine in animal models (Drew et et al al, 2000) and , 2000) and in vivo in vivo human studies human studies (Salokangas (Salokangas et al et al, 2000) ; and a decrease , 2000); and a decrease in antipsychotic blood levels through in antipsychotic blood levels through enzymatic induction. Individuals with enzymatic induction. Individuals with schizophrenia who smoke tend to receive schizophrenia who smoke tend to receive consistently higher doses of antipsychotics consistently higher doses of antipsychotics than non-smokers (Ziedonis than non-smokers (Ziedonis et al et al, 1994; , 1994; de Leon de Leon et al et al, 1995 , 2002 , 1995 , 2002a tend to be treated with higher daily doses of tend to be treated with higher daily doses of antipsychotics than non-smokers. When antipsychotics than non-smokers. When compared with others with severe mental compared with others with severe mental illness in three epidemiological studies in illness in three epidemiological studies in psychiatric hospitals, the effect of antipsychiatric hospitals, the effect of antipsychotic medication did not explain the psychotic medication did not explain the association between schizophrenia and association between schizophrenia and smoking (de Leon smoking (de Leon et al et al, 1995 Leon et al et al, , 2002 Leon et al et al, , 1995 Leon et al et al, , 2002a ; Llerena Llerena et al et al, 2003) . Some cross-sectional , 2003). Some cross-sectional studies have suggested that smoking studies have suggested that smoking reduces antipsychotic side-effects and reduces antipsychotic side-effects and others have not (Dalack others have not (Dalack et al et al, 1998); yet , 1998 ); yet all of these studies are hampered by the lack all of these studies are hampered by the lack of control for confounding factors. Longiof control for confounding factors. Longitudinal studies with small samples suggest tudinal studies with small samples suggest that, when compared with atypical antithat, when compared with atypical antipsychotics, typical antipsychotics are psychotics, typical antipsychotics are associated with increased smoking in some associated with increased smoking in some individuals (McEvoy individuals (McEvoy et al et al, 1995) and with , 1995) and with a greater difficulty for quitting smoking a greater difficulty for quitting smoking (George (George et al et al, 2000) . Anticholinergic medi-, 2000). Anticholinergic medication was not associated significantly with cation was not associated significantly with smoking in this or in previous studies smoking in this or in previous studies (de Leon (de Leon et al et al, 1995 , 2002 , 1995 , 2002a . ). In spite of the hypothesis from animal In spite of the hypothesis from animal studies (Drew studies (Drew et al et al, 2000) , very limited , 2000), very limited clinical data support an association clinical data support an association between smoking and a reduction in between smoking and a reduction in negative symptoms (Dalack negative symptoms (Dalack et al et al, 1998) . , 1998). Data indicating that nicotine may improve Data indicating that nicotine may improve sensory gating abnormalities and smooth sensory gating abnormalities and smooth pursuit eye movements in schizophrenia or pursuit eye movements in schizophrenia or cognitive abnormalities induced by anticognitive abnormalities induced by antipsychotics are somewhat stronger. Nicotine psychotics are somewhat stronger. Nicotine may have antidepressant qualities in indimay have antidepressant qualities in individuals with depression (Salin-Pascual viduals with depression (Salin-Pascual et et al al, 1996) , but this is not well established , 1996), but this is not well established in those with schizophrenia. in those with schizophrenia.
The literature appears to suggest that The literature appears to suggest that those with severe forms of schizophrenia those with severe forms of schizophrenia may smoke more frequently, and more may smoke more frequently, and more heavily, than those with less severe forms heavily, than those with less severe forms (Lohr & Flynn, 1992) . The possible benefi- (Lohr & Flynn, 1992) . The possible beneficial effect of nicotine (and smoking) on cial effect of nicotine (and smoking) on schizophrenic symptoms and antipsychotic schizophrenic symptoms and antipsychotic side-effects may be obscured by this assoside-effects may be obscured by this association between smoking and severe forms ciation between smoking and severe forms of schizophrenia. In summary, a critical of schizophrenia. In summary, a critical reading of the literature lends very limited reading of the literature lends very limited support to the self-medication hypothesis, support to the self-medication hypothesis, but this effect may be obscured by the but this effect may be obscured by the association between severe forms of association between severe forms of schizophrenia and heavy smoking. schizophrenia and heavy smoking.
Limitations and strengths of this Limitations and strengths of this study study
The limitations of the cross-sectional design The limitations of the cross-sectional design make it impossible to prove definitively or make it impossible to prove definitively or to deny that smoking has beneficial effects to deny that smoking has beneficial effects on schizophrenia. It is not ethical to conon schizophrenia. It is not ethical to conduct long-term studies by (ideally) randoduct long-term studies by (ideally) randomising patients to heavy or mild smoking. mising patients to heavy or mild smoking. However, our studyHowever, our study -involving a great involving a great number of stable outnumber of stable out-patients with schizopatients with schizophrenia -like other naturalistic studies, phrenia -like other naturalistic studies, may help to select which individuals are may help to select which individuals are more likely to improve their schizophrenic more likely to improve their schizophrenic symptoms and/or extrapyramidal sidesymptoms and/or extrapyramidal sideeffects using nicotine patches or other nicoeffects using nicotine patches or other nicotine agonists. Because experimental designs tine agonists. Because experimental designs with randomisation (to different levels of with randomisation (to different levels of smoking and lack of smoking) are not smoking and lack of smoking) are not admissible, other naturalistic studies with admissible, other naturalistic studies with large samples, refined assessments and large samples, refined assessments and sophisticated statistical techniques to consophisticated statistical techniques to control for confounders are needed to confirm trol for confounders are needed to confirm these findings. these findings.
Our findings suggest that nicotine Our findings suggest that nicotine dependence and schizophrenic symptomadependence and schizophrenic symptomatology might be statistically dependent in tology might be statistically dependent in out-patients with schizophenia, but the out-patients with schizophenia, but the data imply a complex interaction between data imply a complex interaction between these two variables. Our large sample size these two variables. Our large sample size and the use of a sophisticated statistical and the use of a sophisticated statistical technique, log-linear analysis, made it posstechnique, log-linear analysis, made it possible to control for potential confounding ible to control for potential confounding and interacting variables . and interacting variables . In contrast with other statistical techniques In contrast with other statistical techniques such as multiple linear or logistic regressuch as multiple linear or logistic regression, the log-linear methodology provides sion, the log-linear methodology provides a clearer way to identify and deal with mula clearer way to identify and deal with multiple interactions among several variables. tiple interactions among several variables. In addition, as explained in the statistics In addition, as explained in the statistics section, the methodology used allows the section, the methodology used allows the systematic identification of variables affectsystematic identification of variables affecting the association between nicotine depening the association between nicotine dependence and schizophrenic symptoms, and the dence and schizophrenic symptoms, and the identification of subgroups where this assoidentification of subgroups where this association exists. Finally, the log-linear methciation exists. Finally, the log-linear methodology does not imply the assumption of odology does not imply the assumption of linear relationships among the variables linear relationships among the variables analysed. The results of this study in stable analysed. The results of this study in stable outout-patients with low levels of symptoms patients with low levels of symptoms suggest that such an assumption is unsussuggest that such an assumption is unsustainable. One apparent drawback of logtainable. One apparent drawback of loglinear methodology is the need to transform linear methodology is the need to transform continuous variables into categorical ones. continuous variables into categorical ones. Nonetheless, the amount of information Nonetheless, the amount of information that a log-linear analysis produces compenthat a log-linear analysis produces compensates for the possible loss of some informasates for the possible loss of some information in the transformation . tion in the transformation .
One may argue that the association One may argue that the association between increased frequency of hospitalisabetween increased frequency of hospitalisation and high nicotine dependence may be tion and high nicotine dependence may be partly explained by institutionalisation. partly explained by institutionalisation. However, this is not likely. Our crossHowever, this is not likely. Our crosscultural studies suggest that, although the cultural studies suggest that, although the prevalence of current smoking in the prevalence of current smoking in the general population is influenced by social general population is influenced by social pressure, high nicotine dependence among pressure, high nicotine dependence among smokers with severe psychiatric illness smokers with severe psychiatric illness appears to be similar across countries and appears to be similar across countries and remarkably resistant to social pressure (de remarkably resistant to social pressure (de Leon Leon et al et al, 2002 Leon et al et al, , 2002b . (George et al et al, 2000) . , 2000). The possible alleviation of positive The possible alleviation of positive symptoms by symptoms by chronic chronic nicotine administranicotine administration could be explained by a potential tion could be explained by a potential correction of the cortical-subcortical dissocorrection of the cortical-subcortical dissociation of dopamine activity, which may be ciation of dopamine activity, which may be associated with schizophrenia (Dalack associated with schizophrenia (Dalack et al et al, , 1998) . However, in certain cases of 1998). However, in certain cases of schizophrenia (perhaps the most severe), schizophrenia (perhaps the most severe), 'self-medication', even with higher amounts 'self-medication', even with higher amounts of nicotine -as in our highly dependent of nicotine -as in our highly dependent smokers -would not be effective. smokers -would not be effective.
In summary, if there is any beneficial In summary, if there is any beneficial effect of nicotine it may be restricted to effect of nicotine it may be restricted to mildly dependent smokers, and particularly mildly dependent smokers, and particularly to those on low dosages of typical antito those on low dosages of typical antipsychotics who are sensitive to the psychotics who are sensitive to the extrapyramidal side-effects. Such a benefit extrapyramidal side-effects. Such a benefit appears to affect only certain symptoms. appears to affect only certain symptoms. Our study does not support the selfOur study does not support the selfmedication hypothesis for highly dependent medication hypothesis for highly dependent smokers, who have poorer outcomes smokers, who have poorer outcomes despite their heavy smoking. despite their heavy smoking.
Other symptom differences do not Other symptom differences do not support the self-medication support the self-medication hypothesis hypothesis
In contrast to the positive symptoms, In contrast to the positive symptoms, the analyses of negative, anxious and the analyses of negative, anxious and depressive symptoms in our sample do not depressive symptoms in our sample do not support the self-medication hypothesis. support the self-medication hypothesis. This does not necessarily refute the hypothThis does not necessarily refute the hypothesis; the assessment may not have been esis; the assessment may not have been sensitive enough or the effect size too small sensitive enough or the effect size too small to be apparent with the statistical power in to be apparent with the statistical power in our sample. Taiminen our sample. Taiminen et al et al (1998) similarly (1998) similarly found no differences in negative symptoms found no differences in negative symptoms according to smoking behaviour. Although according to smoking behaviour. Although these two naturalistic studies do not rule these two naturalistic studies do not rule out the possibility of beneficial effects of out the possibility of beneficial effects of nicotine on negative symptoms, they nicotine on negative symptoms, they certainly suggest that the alleviation of certainly suggest that the alleviation of other schizophrenic symptoms is more other schizophrenic symptoms is more likely. Ziedonis likely. Ziedonis et al et al (1994) described (1994) described lower levels of negative symptoms in heavy lower levels of negative symptoms in heavy smokers (and higher levels of positive smokers (and higher levels of positive symptoms), in comparison with light smosymptoms), in comparison with light smokers and non-smokers with schizophrenia. kers and non-smokers with schizophrenia. Goff Goff et al et al (1992) found higher levels of (1992) found higher levels of both negative and positive symptoms in both negative and positive symptoms in smokers than in non-smokers, whereas smokers than in non-smokers, whereas Kelly & McCreadie (1999) were not able Kelly & McCreadie (1999) were not able to demonstrate significant differences to demonstrate significant differences between smokers and non-smokers. between smokers and non-smokers.
The presence of disorganised symptoms The presence of disorganised symptoms was associated with a high dependence on was associated with a high dependence on nicotine in our sample and did not support nicotine in our sample and did not support the self-medication hypothesis. the self-medication hypothesis.
Poor outcome and heavy smoking Poor outcome and heavy smoking Our results suggest that severe forms of Our results suggest that severe forms of schizophrenia with poor outcome, manischizophrenia with poor outcome, manifested by either residual disorganised fested by either residual disorganised symptoms or a greater number of hospital symptoms or a greater number of hospital admissions without residual disorganised admissions without residual disorganised symptoms, were associated with heavy symptoms, were associated with heavy smoking. Certainly if nicotine has some smoking. Certainly if nicotine has some beneficial influence in schizophrenia, it is beneficial influence in schizophrenia, it is not evident in those with a poor outcome. not evident in those with a poor outcome. There are no clear-cut theories to explain There are no clear-cut theories to explain the association between highly dependent the association between highly dependent smoking and poor long-term outcome in smoking and poor long-term outcome in schizophrenia. The most likely underlying schizophrenia. The most likely underlying reason is that these individuals may have reason is that these individuals may have vulnerability to both high nicotine depenvulnerability to both high nicotine dependence and schizophrenia with poor dence and schizophrenia with poor outcome. outcome. High nicotine dependence is associated with poor-outcome schizophrenia.
LIMITATIONS LIMITATIONS
& & The limitations of the cross-sectional design make it impossible to prove The limitations of the cross-sectional design make it impossible to prove definitively or to deny a beneficial effect of smoking on schizophrenia. definitively or to deny a beneficial effect of smoking on schizophrenia.
